Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-12-27

FDA Approved: RAMIPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for ramipril from Hikma Pharmaceuticals USA Inc., likely related to labeling or formulation changes for the ramipril pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramipril (ramipril)

Snippet

SUPPL AP for RAMIPRIL (RAMIPRIL)